Gene · 3438
Papers2,276
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,276
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| 3D vascularised proximal tubules-on-a-multiplexed chip model for enhanced cell phenotypes. | Lab Chip | 2023 | 37341452 | PubTator, text mining | PubMed |
| Serine-arginine splicing factor 2 promotes oesophageal cancer progression by regulating alternative splicing of interferon regulatory factor 3. | RNA Biol | 2023 | 37335045 | PubTator, text mining | PubMed |
| Interleukin 1 beta and its association with the periodontal health of pregnant women. | J Taibah Univ Med Sci | 2023 | 37332485 | PubTator, text mining | PubMed |
| A pharmacoproteomic landscape of organotypic intervention responses in Gram-negative sepsis. | Nat Commun | 2023 | 37330510 | PubTator, text mining | PubMed |
| Effects of gut microbiota on neurodegenerative diseases. | Front Aging Neurosci | 2023 | 37323141 | PubTator, text mining | PubMed |
| Broad-spectrum pan-genus and pan-family virus vaccines. | Cell Host Microbe | 2023 | 37321173 | PubTator, text mining | PubMed |
| Low-dose radiotherapy effects the progression of anti-tumor response. | Transl Oncol | 2023 | 37320873 | PubTator, text mining | PubMed |
| Recent progress on tyrosine kinase 2 JH2 inhibitors. | Int Immunopharmacol | 2023 | 37315371 | PubTator, text mining | PubMed |
| Sensitivity to Neutralizing Antibodies and Resistance to Type I Interferons in SARS-CoV-2 R.1 Lineage Variants, Canada. | Emerg Infect Dis | 2023 | 37308158 | PubTator, text mining | PubMed |
| Retinal microvascular and microstructural alterations in the diagnosis of dermatomyositis: a new approach. | Front Med (Lausanne) | 2023 | 37305140 | PubTator, text mining | PubMed |
| Ubiquitin-specific protease 29 attenuates hepatic ischemia-reperfusion injury by mediating TGF-β-activated kinase 1 deubiquitination. | Front Immunol | 2023 | 37304282 | PubTator, text mining | PubMed |
| Emission and Migration of Nanoscale Particles during Osseointegration and Disintegration of Dental Implants in the Clinic and Experiment and the Influence on Cytokine Production. | Int J Mol Sci | 2023 | 37298627 | PubTator, text mining | PubMed |
| Progress towards Adjuvant Development: Focus on Antiviral Therapy. | Int J Mol Sci | 2023 | 37298177 | PubTator, text mining | PubMed |
| Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study. | Cancers (Basel) | 2023 | 37296954 | PubTator, text mining | PubMed |
| Hope and Hype around Immunotherapy in Triple-Negative Breast Cancer. | Cancers (Basel) | 2023 | 37296893 | PubTator, text mining | PubMed |
| High-throughput sequencing technology facilitates the discovery of novel biomarkers for antiphospholipid syndrome. | Front Immunol | 2023 | 37275905 | PubTator, text mining | PubMed |
| Human social genomics: Concepts, mechanisms, and implications for health. | Lifestyle Med (Hoboken) | 2023 | 37275556 | PubTator, text mining | PubMed |
| The role of PD-1 signaling in health and immune-related diseases. | Front Immunol | 2023 | 37261359 | PubTator, text mining | PubMed |
| Review of Neurological Manifestations of SARS-CoV-2. | Cureus | 2023 | 37257164 | PubTator, text mining | PubMed |
| Variant STAT4 and Response to Ruxolitinib in an Autoinflammatory Syndrome. | N Engl J Med | 2023 | 37256972 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3438/papers?page=14